Brief: Sedana Medical Q2 Sales SEK 49.8 Million
18/07/2025 06:00
Jul 18 (Reuters) - Sedana Medical Q2 EBITDA SEK -4.1 million. Q2 EBIT margin -19% Q2 cash flow from operating activities SEK -12.5 million Q2 net income SEK -13.3 million Q2 adjusted EPS SEK -0.13
Recent news on Sedana Medical AB (publ)
See all newsSweden's Sedana Medical Q3 sales rise as growth returns
Brief: Sedana Medical Announces PDUFA Target Action Date
Brief: Sedana Medical Announces FDA Acceptance For Review Of Its New Drug Application In U.S.
Sweden's Sedana Medical Q2 sales flat, EBITDA loss narrows
Brief: Sedana Medical Q2 EBITDA Loss Narrows To SEK 1.9 Mln